drugset / Trial / NCT05762458
The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Ammoxetine hydrochloride enteric-coated tablets in subjects with depression.
Timeline
- Start
- 2023-02-28
- Primary completion
- 2024-05-15
- Completion
- 2024-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ammoxetine | Unknown | 40 mg | — |
| Subject | Ammoxetine | Unknown | 60 mg | — |